You are here: Home » News-CM » Companies » News
Business Standard

Dai-ichi Karkaria announces conclusion of agreement with GVK Bio & Inogent

Capital Market 

Pares stake in Inogent

Dai-ichi Karkaria announced that pursuant to the Call Option under the Joint Venture and Shareholders Agreement among GVK Biosciences (GVK Bio), Dai-Ichi Karkaria (the Company) and Inogent Laboratories (Inogent), dated 14 October 2005, GVK Bio has acquired balance 9,87,500 equity shares (6.12% of voting powers) of Inogent from the Company on 11 July 2014, at a consideration aggregating to Rs. 8.97 crore.

Accordingly, the shareholding of the Company in Inogent after the acquisition will be NIL and the Agreement shall be treated as concluded.

Powered by Capital Market - Live News

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Mon, July 14 2014. 15:29 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU